Immediate Impact

6 by Nobel laureates 7 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
2022 Standout
Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials
2022 Standout
2 intermediate papers

Works of Thomas M. Farley being referenced

Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment: An Alternative Viewpoint
2017
Traumatic spinal cord injury in Arkansas, 1980 to 1989
1993

Author Peers

Author Last Decade Papers Cites
Thomas M. Farley 148 25 28 68 47 42 398
Z. Verjee 106 4 18 29 6 34 455
Martin D. Keller 69 26 39 16 8 29 435
Robert C. Wood 112 25 31 10 29 29 400
Cyril Breuker 110 1 26 74 6 31 391
A. Parra 62 21 31 25 31 369
V. C. Vaughan 127 3 28 49 17 22 447
Xiao Chen 73 15 13 46 15 31 408
Ying Xing 85 7 7 23 24 45 437
M Welsch 89 21 31 43 8 75 369
Xinmei Zhou 97 6 25 8 17 26 341

All Works

Loading papers...

Rankless by CCL
2026